Second Affiliated Hospital, Zhejiang University, School of Medicine
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- The study included all patients who underwent VA-ECMO and in whom Perclose ProGlide was deployed to achieve hemostasis during closure of the CFA site.
You may not be if
Patients were excluded if 24 hour and 30-day follow-up data regarding the access sites and other clinical outcomes were not available.
Clareo Health | Feasibility and Safety of Total Percutaneous Closure of Femoral Arterial Access Sites in the Veno-arterial ECMO Patients
